Neuroleptic malignant-like syndrome induced by metoclopramide.
A prompt recognition of neuroleptic malignant-like syndrome is essential because of its high morbidity and mortality. A similar condition i described associated with metoclopramide, an agent with dopamine receptor-blocking properties. An increased index of suspicion for early diagnosis of this condition and adjustment of metoclopramide dosing in patients with renal failure are emphasized.
D000368:Aged; D003402:Creatine Kinase / Q000097:blood; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000008:administration & dosage / Q000009:adverse effects*; D009459:Neuroleptic Malignant Syndrome / Q000201:enzymology / Q000209:etiology*
D003402:Creatine Kinase; D008787:Metoclopramide